Cardiovascular and Kidney Outcomes of Glucagon-Like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Cardiovascular and Kidney Outcomes of Glucagon-Like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Introduction: The effects of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in patients with diabetes and established chronic kidney disease (CKD) remain unclear. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to May 2024 for randomized contr...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicole Felix, Mateus M. Gauza, Vinicius Bittar, Alleh Nogueira, Thomaz A. Costa, Amanda Godoi, Larissa Araújo de Lucena, Ocílio Ribeiro Gonçalves, Luís Cláudio Santos Pinto, Lucas Tramujas, José A. Moura-Neto, Maria Gabriela Guimarães
Format: Article
Language:English
Published: Karger Publishers 2025-01-01
Series:Cardiorenal Medicine
Online Access:https://karger.com/article/doi/10.1159/000543149
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://karger.com/article/doi/10.1159/000543149

Similar Items